Mecastrin (Melatonin)

Melatonin in Mecastrin binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, signaling that it is night time. This interaction reduces neuronal activity that promotes wakefulness, facilitating the onset of sleep and helping to synchronize circadian rhythms.

The appropriate dose of Mecastrin is determined by the prescribing healthcare professional based on the individual’s condition, age, and response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mecastrin.

To order Mecastrin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike many prescription hypnotics, Mecastrin’s melatonin acts as a physiological hormone that aligns the body’s sleep‑wake cycle rather than directly depressing the central nervous system. This generally results in fewer next‑day sedation effects, but efficacy may vary depending on the specific sleep disorder.

Mecastrin should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Mecastrin is taken orally, usually with a glass of water. It is commonly recommended to take the product 30‑60 minutes before the desired bedtime, but patients should follow the timing advised by their prescriber.

Serious risks, though rare, include severe allergic reactions such as rash, swelling, or difficulty breathing, and significant hormonal effects that may alter menstrual cycles or mood. Any unexpected or severe symptoms should prompt immediate medical attention.

Individuals with known hypersensitivity to melatonin, those taking certain anticoagulants, immunosuppressants, or CNS depressants without medical supervision, and patients with uncontrolled endocrine disorders should avoid Mecastrin unless directed otherwise by a qualified healthcare professional.